ArticleEuropean journal of nuclear medicine and molecular imaging2020

Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors.

Romain-David Seban et al.PubMed ↗Publisher ↗

No numbers read from the abstract.